rxstat › Shortages › Baloxavir Marboxil

Baloxavir Marboxil (Xofluza) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 15, 2026

Some Baloxavir Marboxil products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

An antiviral medication used to treat influenza.

Products affected
1 / 1
In shortage since
Apr 22, 2026
Reports on file
1
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

Active shortage
XOFLUZA
20MG · TABLET · HOFFMANN-LA ROCHE LIMITED
DIN 02496364 · since Apr 22, 2026, no end estimate

What's happening

Baloxavir Marboxil is currently affected by an active shortage report filed with Health Canada by HOFFMANN-LA ROCHE LIMITED.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Recent changes

Common questions

What is Baloxavir Marboxil used for?

An antiviral medication used to treat influenza.

When will Baloxavir Marboxil be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Baloxavir Marboxil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Inosine Pranobex (Imunovir) No current shortage Letermovir (Prevymis) No current shortage Nirmatrelvir Ritonavir (Paxlovid) No current shortage Adefovir Dipivoxil (Hepsera) Partial shortage 1 of 2 reported products affected Atazanavir (Reyataz) Partial shortage 3 of 8 reported products affected Darunavir (Prezista) Partial shortage 2 of 9 reported products affected · est. return Jul 31, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.